176 related articles for article (PubMed ID: 33023587)
1. A novel phenotype of 13q12.3 microdeletion characterized by epilepsy in an Asian child: a case report.
Wang M; Li B; Liao Z; Jia Y; Fu Y
BMC Med Genomics; 2020 Oct; 13(1):144. PubMed ID: 33023587
[TBL] [Abstract][Full Text] [Related]
2. A de novo 3.57 Mb microdeletion in 8q12.3q13.2 in a patient with mild intellectual disability and epilepsy.
Verhoeven WM; Egger JI; Feenstra I; de Leeuw N
Eur J Med Genet; 2012 May; 55(5):358-61. PubMed ID: 22138216
[TBL] [Abstract][Full Text] [Related]
3. A newly recognized 13q12.3 microdeletion syndrome characterized by intellectual disability, microcephaly, and eczema/atopic dermatitis encompassing the HMGB1 and KATNAL1 genes.
Bartholdi D; Stray-Pedersen A; Azzarello-Burri S; Kibaek M; Kirchhoff M; Oneda B; Rødningen O; Schmitt-Mechelke T; Rauch A; Kjaergaard S
Am J Med Genet A; 2014 May; 164A(5):1277-83. PubMed ID: 24664804
[TBL] [Abstract][Full Text] [Related]
4. 15q11.2 microdeletion (BP1-BP2) and developmental delay, behaviour issues, epilepsy and congenital heart disease: a series of 52 patients.
Vanlerberghe C; Petit F; Malan V; Vincent-Delorme C; Bouquillon S; Boute O; Holder-Espinasse M; Delobel B; Duban B; Vallee L; Cuisset JM; Lemaitre MP; Vantyghem MC; Pigeyre M; Lanco-Dosen S; Plessis G; Gerard M; Decamp M; Mathieu M; Morin G; Jedraszak G; Bilan F; Gilbert-Dussardier B; Fauvert D; Roume J; Cormier-Daire V; Caumes R; Puechberty J; Genevieve D; Sarda P; Pinson L; Blanchet P; Lemeur N; Sheth F; Manouvrier-Hanu S; Andrieux J
Eur J Med Genet; 2015 Mar; 58(3):140-7. PubMed ID: 25596525
[TBL] [Abstract][Full Text] [Related]
5. 15q24.1 BP4-BP1 microdeletion unmasking paternally inherited functional polymorphisms combined with distal 15q24.2q24.3 duplication in a patient with epilepsy, psychomotor delay, overweight, ventricular arrhythmia.
Huynh MT; Lambert AS; Tosca L; Petit F; Philippe C; Parisot F; Benoît V; Linglart A; Brisset S; Tran CT; Tachdjian G; Receveur A
Eur J Med Genet; 2018 Aug; 61(8):459-464. PubMed ID: 29549028
[TBL] [Abstract][Full Text] [Related]
6. A de novo 2.1-Mb deletion of 13q12.11 in a child with developmental delay and minor dysmorphic features.
Der Kaloustian VM; Russell L; Aradhya S; Richard G; Rosenblatt B; Melançon S
Am J Med Genet A; 2011 Oct; 155A(10):2538-42. PubMed ID: 22043489
[TBL] [Abstract][Full Text] [Related]
7. RORB gene and 9q21.13 microdeletion: report on a patient with epilepsy and mild intellectual disability.
Baglietto MG; Caridi G; Gimelli G; Mancardi M; Prato G; Ronchetto P; Cuoco C; Tassano E
Eur J Med Genet; 2014 Jan; 57(1):44-6. PubMed ID: 24355400
[TBL] [Abstract][Full Text] [Related]
8. De novo duplication of chromosome 13(q32-q34) in a child with developmental delay.
Milani D; D'Arrigo S; Guerneri S; Selicorni A; Riva D; Pantaleoni C
J Child Neurol; 2006 Dec; 21(12):1084-5. PubMed ID: 17156706
[TBL] [Abstract][Full Text] [Related]
9. Heterozygous HMGB1 loss-of-function variants are associated with developmental delay and microcephaly.
Uguen K; Krysiak K; Audebert-Bellanger S; Redon S; Benech C; Viora-Dupont E; Tran Mau-Them F; Rondeau S; Elsharkawi I; Granadillo JL; Neidich J; Soares CA; Tkachenko N; M Amudhavalli S; Engleman K; Boland A; Deleuze JF; Bezieau S; Odent S; Toutain A; Bonneau D; Gilbert-Dussardier B; Faivre L; Rio M; Le Marechal C; Ferec C; Repnikova E; Cao Y
Clin Genet; 2021 Oct; 100(4):386-395. PubMed ID: 34164801
[TBL] [Abstract][Full Text] [Related]
10. Novel de novo TRIP12 mutation reveals variable phenotypic presentation while emphasizing core features of TRIP12 variations.
Donoghue T; Garrity L; Ziolkowski A; McPhillips M; Buckman M; Goel H
Am J Med Genet A; 2020 Jul; 182(7):1801-1806. PubMed ID: 32424948
[TBL] [Abstract][Full Text] [Related]
11. De novo variants in SETD1B are associated with intellectual disability, epilepsy and autism.
Hiraide T; Nakashima M; Yamoto K; Fukuda T; Kato M; Ikeda H; Sugie Y; Aoto K; Kaname T; Nakabayashi K; Ogata T; Matsumoto N; Saitsu H
Hum Genet; 2018 Jan; 137(1):95-104. PubMed ID: 29322246
[TBL] [Abstract][Full Text] [Related]
12. A novel FBXO28 frameshift mutation in a child with developmental delay, dysmorphic features, and intractable epilepsy: A second gene that may contribute to the 1q41-q42 deletion phenotype.
Balak C; Belnap N; Ramsey K; Joss S; Devriendt K; Naymik M; Jepsen W; Siniard AL; Szelinger S; Parker ME; Richholt R; Izatt T; LaFleur M; Terraf P; Llaci L; De Both M; Piras IS; Rangasamy S; Schrauwen I; Craig DW; Huentelman M; Narayanan V
Am J Med Genet A; 2018 Jul; 176(7):1549-1558. PubMed ID: 30160831
[TBL] [Abstract][Full Text] [Related]
13. 6p21.3 microdeletion involving the SYNGAP1 gene in a patient with intellectual disability, seizures, and severe speech impairment.
Writzl K; Knegt AC
Am J Med Genet A; 2013 Jul; 161A(7):1682-5. PubMed ID: 23687080
[TBL] [Abstract][Full Text] [Related]
14. [Identification of a de novo interstitial 21q22.12q22.13 deletion in a patient with intellectual disability].
Peng Y; Jia Z; Pang J; Hu J; Xi H; Wang H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jul; 36(7):704-707. PubMed ID: 31302916
[TBL] [Abstract][Full Text] [Related]
15. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
[TBL] [Abstract][Full Text] [Related]
16. Neurological features and long-term follow-up in 15q11.2-13.1 duplication.
Coppola A; Ruosi P; Santulli L; Striano S; Zara F; Striano P; Sisodiya SM
Eur J Med Genet; 2013 Nov; 56(11):614-8. PubMed ID: 24075935
[TBL] [Abstract][Full Text] [Related]
17. Expansion and further delineation of the SETD5 phenotype leading to global developmental delay, variable dysmorphic features, and reduced penetrance.
Powis Z; Farwell Hagman KD; Mroske C; McWalter K; Cohen JS; Colombo R; Serretti A; Fatemi A; David KL; Reynolds J; Immken L; Nagakura H; Cunniff CM; Payne K; Barbaro-Dieber T; Gripp KW; Baker L; Stamper T; Aleck KA; Jordan ES; Hersh JH; Burton J; Wentzensen IM; Guillen Sacoto MJ; Willaert R; Cho MT; Petrik I; Huether R; Tang S
Clin Genet; 2018 Apr; 93(4):752-761. PubMed ID: 28881385
[TBL] [Abstract][Full Text] [Related]
18. Refinement of the deletion in 8q22.2-q22.3: the minimum deletion size at 8q22.3 related to intellectual disability and epilepsy.
Kuroda Y; Ohashi I; Saito T; Nagai J; Ida K; Naruto T; Iai M; Kurosawa K
Am J Med Genet A; 2014 Aug; 164A(8):2104-8. PubMed ID: 24801133
[TBL] [Abstract][Full Text] [Related]
19. A de novo PAK1 likely pathogenic variant and a de novo terminal 1q microdeletion in a Chinese girl with global developmental delay, severe intellectual disability, and seizures.
Zhuang J; Xie M; Yao J; Fu W; Zeng S; Jiang Y; Wang Y; Xie Y; Wang G; Chen C
BMC Med Genomics; 2023 Jan; 16(1):3. PubMed ID: 36624491
[TBL] [Abstract][Full Text] [Related]
20. Prenatal detection of a 3q29 microdeletion in a fetus with ventricular septum defect: A case report and literature review.
Yue F; Deng S; Xi Q; Jiang Y; He J; Zhang H; Liu R
Medicine (Baltimore); 2021 Jan; 100(1):e24224. PubMed ID: 33429816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
